Listed

NeuroPace Inc

NPCENasdaqCIK 1528287HealthcareFiscal year ends Dec 31

Reports and events: 83 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

NeuroPace Inc, Reports and events
FiledFormWhat it isAccession number
2023-06-2816:06 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-23-177492
2023-06-1216:14 ET8-K5.07 Shareholder vote results0001528287-23-000028
2023-05-0417:04 ET10-QQuarterly reportPeriod 2023-03-310001528287-23-000026
2023-05-0416:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-23-000024
2023-04-2517:27 ETDEF 14AProxy statementPeriod 2023-06-070001140361-23-020294
2023-04-1316:39 ET8-K5.02 Departure or appointment of officers or directors0001193125-23-100628
2023-03-0217:14 ET10-KAnnual reportPeriod 2022-12-310001528287-23-000007
2023-03-0216:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-23-000005
2023-01-0916:10 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-004750
2022-11-2317:11 ETSC 13D/AOwnership report, active investor, amended0001193125-22-292096
2022-11-2107:00 ETSC 13DOwnership report, active investor0001193125-22-289488
2022-11-0816:06 ET10-QQuarterly reportPeriod 2022-09-300001528287-22-000027
2022-11-0816:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-22-000026
2022-08-1117:10 ET10-QQuarterly reportPeriod 2022-06-300001528287-22-000019
2022-08-1116:07 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-22-000017
2022-06-1716:34 ET8-K5.07 Shareholder vote results0001193125-22-176557
2022-05-1217:19 ET10-QQuarterly reportPeriod 2022-03-310001528287-22-000012
2022-05-1216:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-22-000011
2022-04-2216:31 ETDEF 14AProxy statementPeriod 2022-06-130001140361-22-015589
2022-03-1017:19 ET10-KAnnual reportPeriod 2021-12-310001528287-22-000006
2022-03-1016:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-22-000004
2022-01-1116:16 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-006746
2021-11-1017:06 ET10-QQuarterly reportPeriod 2021-09-300001528287-21-000018
2021-11-1016:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-21-000017
2021-10-1916:30 ET8-K5.02 Departure or appointment of officers or directors0001193125-21-302022
2021-09-0916:57 ET8-K7.01 Regulation FD disclosure0001528287-21-000013
2021-08-1217:10 ET10-QQuarterly reportPeriod 2021-06-300001528287-21-000011
2021-08-1216:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-21-000009
2021-06-0316:41 ET10-QQuarterly reportPeriod 2021-03-310001528287-21-000006
2021-06-0307:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-21-000003
2021-04-2616:31 ET8-K5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001628280-21-007595
2021-04-1406:09 ETS-1/ARegistration statement, amended0001628280-21-006852
2021-03-2417:03 ETS-1Registration statement0001628280-21-005481

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:24 ET. Listed shows no prices and gives no investment advice.